Inducing Tumor Immunity by Specific Tumor Antigens
Schwind, J.V.
Oncology 32(5-6): 324-326
1975
ISSN/ISBN: 0030-2414
DOI: 10.1159/000225083
Accession: 067791173
PDF emailed within 0-6 h: $19.90
Related References
Pellis, N.R.; Shulan, D.J.; Kahan, B.D. 1976: Specific tumor immunity induced with soluble materials: purification of antigens inducing tumor resistance Biochemical and Biophysical Research Communications 71(4): 1251-1258Schwind, J.V. 1975: Inducing tumor immunity by specific tumor antigens Oncology 32(5-6): 324-326
Sano, S.; Izumi, Y.; Sugihara, S.; Nakajima, H.; Fujiwara, H.; Hamaoka, T. 1987: The generation of tumor-specific in vivo protective immunity in the tumor mass from mice rendered tolerant to tumor antigens Cancer Immunology Immunotherapy: Cii 25(2): 105-110
Brannen, G.E.; Adams, J.S.; Santos, G.W. 1974: In vivo demonstration of tumor specific immunity with soluble tumor antigens in the mouse Proceedings of the American Association for Cancer Research 15: 76
Lewis, J.D.; Patterson, E.K.; Shearer, M.H.; Kennedy, R.C.; Bright, R.K. 2003: Vaccine strategies to induce tumor-specific immunity in the absence of known tumor associated antigens Proceedings of the American Association for Cancer Research Annual Meeting 44: 169
Chism, S.E.; Burton, R.C.; Warner, N.L. 1977: In vitro induction of tumor specific immunity assessment of specificity of response to tumor antigens Proceedings of the American Association for Cancer Research 18: 26
Schroit, A.J.; Key, M.E. 1983: Induction of syngeneic tumour-specific immunity by liposomes reconstituted with L2C tumour-cell antigens Immunology 49(3): 431-438
Bergers, J.J.; Den Otter, W.; Dullens, H.F.; De Groot, J.W.; Steerenberg, P.A.; Filius, P.M.; Crommelin, D.J. 1994: Effect of immunomodulators on specific tumor immunity induced by liposome-encapsulated tumor-associated antigens International Journal of Cancer 56(5): 721-726
Meltzer, M.S.; Oppenheim, J.J.; Littman, B.H.; Leonard, E.J.; Rapp, H.J. 1972: Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens Journal of the National Cancer Institute 49(3): 727-734
Yoshioka, T.; Fukuzawa, M.; Takai, Y.; Wakamiya, N.; Ueda, S.; Kato, S.; Fujiwara, H.; Hamaoka, T. 1986: The augmentation of tumor-specific immunity by virus help. III. Enhanced generation of tumor-specific Lyt-1+2- T cells is responsible for augmented tumor immunity in vivo Cancer Immunology Immunotherapy: Cii 21(3): 193-198
Rao, V.S.; Bonavida, B. 1976: Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens Cancer Research 36(4): 1384-1391
Hui, K.M.; Kim, B.S. 1984: Tumor-specific immunity induced by somatic hybrids. IV. Relationship between immunogenicity and expression of surface tumor-associated antigens Cellular Immunology 87(2): 591-600
Hanna, M.G.Jr; Bucana, C. 1975: Possible mechanisms of bcg immuno therapy tumor specific immunity and cross reacting antigens of bcg and tumor cell surface Crispen, Ray G (Ed ) Neoplasm Immunity: Theory And Application Proceedings Of A Chicago Symposium Chicago, Ill , U S A , Sept 11, 1974 Vii+204p Illus Itr Biomedical Research, University Of Illinois: Chicago, Ill , U S A ISBN 0-915314-02-9: 65-85
Mortarini, R.; Piris, A.; Maurichi, A.; Molla, A.; Bersani, I.; Bono, A.; Bartoli, C.; Santinami, M.; Lombardo, C.; Ravagnani, F.; Cascinelli, N.; Parmiani, G.; Anichini, A. 2003: Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma Cancer Research 63(10): 2535-2545
Wu, Y.; Wan, Y.; Bian, J.; Zhao, J.; Jia, Z.; Zhou, L.; Zhou, W.; Tan, Y. 2002: Phage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine P815 model International Journal of Cancer 98(5): 748-753